← Back to Search

Behavioural Intervention

Computerized Stethoscope for Heart Disease

N/A
Recruiting
Led By Rajiv Gulati, MD, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 18 years of age or older
Individuals with normal heart sounds, isolated aortic stenosis (any degree of severity), or isolated mitral regurgitation (any degree of severity)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial will test whether a new AI-assisted stethoscope can detect heart abnormalities as well as current standard tests.

Who is the study for?
This trial is for adults who need routine heart checks using echocardiography or cardiac catheterization. It's suitable for those with normal heart sounds, aortic stenosis, or mitral regurgitation. People with unstable heart/lung conditions or multiple valve diseases cannot participate.Check my eligibility
What is being tested?
The study tests the ©VoqX stethoscope that records heart sounds and uses artificial intelligence to detect abnormalities, comparing its results to standard echocardiograms and cardiac catheterizations.See study design
What are the potential side effects?
Since this trial involves non-invasive listening to heart sounds with a computerized stethoscope, there are no direct side effects associated with the intervention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
My heart sounds are normal, or I have aortic stenosis or mitral regurgitation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
collecting computerized auscultation data in a time-efficient manner at the bedside is feasible

Trial Design

1Treatment groups
Experimental Treatment
Group I: Computerized AuscultationExperimental Treatment1 Intervention
Patients presenting to the echocardiogram laboratory for routine clinically indicated echocardiography or to the cardiac catheterization laboratory for routine clinically indicated catheterization procedures will undergo a computerized auscultation using the ©VoqX stethoscope and will have their heart sounds auscultated and recorded.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,207 Previous Clinical Trials
3,765,752 Total Patients Enrolled
Rajiv Gulati, MD, PhDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
20 Total Patients Enrolled

Media Library

©CompuSteth stethoscope (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04960280 — N/A
Aortic Stenosis Research Study Groups: Computerized Auscultation
Aortic Stenosis Clinical Trial 2023: ©CompuSteth stethoscope Highlights & Side Effects. Trial Name: NCT04960280 — N/A
©CompuSteth stethoscope (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04960280 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is this clinical trial being utilized by patients?

"Confirmed. Clinicaltrials.gov reveals that this experiment, which was first listed on September 3rd 2021, is presently enrolling participants. Around 400 research subjects need to be sourced from 1 location."

Answered by AI

Are there any vacancies left for participants in this clinical investigation?

"This clinical trial is still open for enrolment. According to the information on clinicialtrials.gov, it was first posted on September 3rd 2021 and has been amended as recently as December 1st 2022."

Answered by AI
~0 spots leftby May 2024